Cardiac Resynchronization Therapy Market Is Expected To Achieve A Market Value Of US$ 6.2 Billion By 2022

Cardiac Resynchronization Therapy

Cardiac Resynchronization Therapy Market Analysis by Product Type (CRT-Defibrillator, RT-Pacemaker), by End-user Type, by Region – Global Forecast 2022-2032 Newly-released Cardiac Resynchronization Therapy industry analysis report by Fact.MR shows that global sales of Cardiac Resynchronization Therapy in 2021 were held at US$ 5.7 Bn. With 7.9%, the projected market growth during 2022-2032 is expected to be slightly lower than the historical growth. CRT-Defibrillator is expected to be the higher revenue-generating product, accounting for an absolute dollar opportunity of nearly US$ 4 Bn during 2022 – 2032.

To remain ‘ahead’ of your competitors, request a sample –

Prominent Key players of the Cardiac Resynchronization Therapy market survey report:

  • Medtronic
  • Boston Scientific
  • Abbott Laboratories
  • Biotronik
  • MicroPort Scientific Corporation
  • Medico
  • Scranton Gillette

Market Segments Covered in Cardiac Resynchronization Therapy Industry Analysis

  • By Product Type :
    • CRT-Defibrillator
    • CRT-Pacemaker
  • By End-user Type :
    • Hospital
    • Cardiac Center
    • Other End-users
  • By region :
    • North America
    • Latin America
    • Europe
    • APAC
    • MEA